Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma. | Pigment Cell Melanoma Res | 2021 | 32567790 | PubTator, text mining | PubMed |
| DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3. | Carcinogenesis | 2021 | 32531052 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma, novel therapies on the horizon. | Chin Clin Oncol | 2021 | 32527116 | PubTator, text mining | PubMed |
| Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms. | Cancer Gene Ther | 2021 | 32457487 | PubTator, text mining | PubMed |
| Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. | Hepatology | 2021 | 32017145 | PubTator, text mining | PubMed |
| MAGEA3 serves as an independent indicator for predicting the prognosis of ESCC. | Panminerva Med | 2021 | 31355595 | PubTator, text mining | PubMed |
| A transcriptomic analysis of malignant transformation of human embryonic esophageal epithelial cells by HPV18 E6E7. | Transl Cancer Res | 2020 | 35117529 | PubTator, text mining | PubMed |
| Review of non-invasive urinary biomarkers in bladder cancer. | Transl Cancer Res | 2020 | 35117265 | PubTator, text mining | PubMed |
| CAR T Cell Therapy-Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity? | JACC CardioOncol | 2020 | 34396213 | PubTator, text mining | PubMed |
| An Antigen-Delivery Protein Nanoparticle Combined with Anti-PD-1 Checkpoint Inhibitor Has Curative Efficacy in an Aggressive Melanoma Model. | Adv Ther (Weinh) | 2020 | 34141865 | PubTator, text mining | PubMed |
| Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma. | Front Oncol | 2020 | 33718105 | PubTator, text mining | PubMed |
| Functional assays to assess the therapeutic potential of extracellular vesicles. | J Extracell Vesicles | 2020 | 33708360 | PubTator, text mining | PubMed |
| Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs. | Curr Oncol | 2020 | 33704184 | PubTator, text mining | PubMed |
| Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis. | Front Mol Biosci | 2020 | 33681288 | PubTator, text mining | PubMed |
| Adjuvant Therapy of High-Risk (Stages IIC-IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis. | Front Oncol | 2020 | 33680957 | PubTator, text mining | PubMed |
| Dendritic Cell-Based Immunotherapy in Lung Cancer. | Front Immunol | 2020 | 33679709 | PubTator, text mining | PubMed |
| Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. | Front Immunol | 2020 | 33679703 | PubTator, text mining | PubMed |
| Hepatitis B Virus Infection Among Leprosy Patients: A Case for Polymorphisms Compromising Activation of the Lectin Pathway and Complement Receptors. | Front Immunol | 2020 | 33643280 | PubTator, text mining | PubMed |
| Exploring the Effect of Differentially Expressed Long Non-coding RNAs Driven by Copy Number Variation on Competing Endogenous RNA Network by Mining Lung Adenocarcinoma Data. | Front Cell Dev Biol | 2020 | 33585468 | PubTator, text mining | PubMed |
| Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities. | Front Oncol | 2020 | 33585226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=50